Skip to main navigation
Skip to search
Skip to main content
Prince Sattam bin Abdulaziz University Home
Home
Profiles
Research units
Projects
Research output
Prizes
Activities
Search by expertise, name or affiliation
Advances in the Lung Cancer Immunotherapy Approaches
Hafiza Padinharayil
, Reema Rose Alappat
, Liji Maria Joy
, Kavya V. Anilkumar
, Cornelia M. Wilson
, Alex George
, Abilash Valsala Gopalakrishnan
, Harishkumar Madhyastha
,
Thiyagarajan Ramesh
, Ezhaveni Sathiyamoorthi
, Jintae Lee
, Raja Ganesan
Basic Medical Sciences
Jubilee Mission Medical College Hospital and Research Center
Canterbury Christ Church University
Vellore Institute of Technology
University of Miyazaki
Yeungnam University
Hallym University
Research output
:
Contribution to journal
›
Review article
›
peer-review
12
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Advances in the Lung Cancer Immunotherapy Approaches'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Adjuvant Therapy
20%
Antigenicity
20%
Biological Marker
20%
Cancer Immunotherapy
100%
Cancer Model
20%
Combination Therapy
20%
Immune Checkpoint Inhibitor
80%
Immune System
40%
Immunology
20%
Immunotherapy
100%
Lung Cancer
100%
Malignant Neoplasm
40%
Microsatellite Instability
20%
Neoplasm
20%
Predictive Marker
40%
Regulatory T Cell
20%
Stroma
20%
Tumor Infiltrating Lymphocyte
20%
Tumor Vaccine
20%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
16%
Cancer Model
16%
Combination Therapy
16%
Immune Checkpoint Inhibitor
66%
Immunotherapy
100%
Lung Cancer
100%
Malignant Neoplasm
33%
Neoplasm
50%
Tumor Vaccine
16%
Biochemistry, Genetics and Molecular Biology
Anticancer
25%
Antigenicity
25%
Cancer Immunotherapy
100%
Cancer Model
25%
Immune Checkpoints
100%
Lymphocyte
25%
Microsatellite Instability
25%
Myeloid
25%
Tumor-Infiltrating Lymphocytes
25%
Immunology and Microbiology
Antigenicity
20%
Cancer Immunotherapy
100%
Immune System
40%
Immunology
20%
Immunotherapy
100%
Regulatory T Cell
40%
Stroma
20%